Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • High-dose opioid prescribing continues to climb in Canada

  • Sleep disorders widely undiagnosed in individuals with multiple sclerosis

  • Unemployment for doctoral scientists, engineers below American national average in 2013

  • Mindfulness protects adults' health from the impacts of childhood adversity

  • Epilepsy breakthrough may lead to non-pharmacological therapies

  • To curb violent tendencies, start young

  • Young women involve parent in abortion when anticipating support

  • Everyday discrimination impacts mental health

  • This is your brain on snacks: Brain stimulation affects craving, consumption

  • Largest ever study of awareness during general anesthesia identifies risk factors and consequences

  •